1,773 research outputs found
Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice
Brown adipose tissue (BAT) dysfunction in aging and obesity has been related to
chronic unresolved inflammation, which could be mediated by an impaired production
of specialized proresolving lipid mediators (SPMs), such as Lipoxins-LXs,
Resolvins-Rvs,
Protectins-PDs,
and Maresins-MaRs.
Our aim was to characterize the
changes in BAT SPMs signatures and their association with BAT dysfunction during
aging, especially under obesogenic conditions, and their modulation by a docosahexaenoic
acid (DHA)-rich
diet. Lipidomic, functional, and molecular studies were performed
in BAT of 2-and
18-month-
old
lean (CT) female mice and in 18-month-
old
diet-induced
obese (DIO) mice fed with a high-fat
diet (HFD), or a DHA-enriched
HFD. Aging downregulated Prdm16 and UCP1 levels, especially in DIO mice,
while DHA partially restored them. Arachidonic acid (AA)-derived
LXs and DHA-derived
MaRs and PDs were the most abundant SPMs in BAT of young CT mice.Interestingly, the sum of LXs and of PDs were significantly lower in aged DIO mice
compared to young CT mice. Some of the SPMs most significantly reduced in obese-aged
mice included LXB4, MaR2, 4S,14S-diHDHA,
10S,17S-diHDHA
(a.k.a. PDX),
and RvD6. In contrast, DHA increased DHA-derived
SPMs, without modifying LXs.
However, MicroPET studies showed that DHA was not able to counteract the impaired
cold exposure response in BAT of obese-aged
mice. Our data suggest that a
defective SPMs production could underlie the decrease of BAT activity observed in
obese-aged
mice, and highlight the relevance to further characterize the physiological
role and therapeutic potential of specific SPMs on BAT development and function
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon
alpha-Interferon therapy normalizes aminotransferase levels in approximately 50% of the patients with chronic hepatitis C, but post-therapy relapses are common and predictive factors of sustained response remain largely unknown. We retrospectively assessed several parameters as predictors of sustained remission after a 12-month course of lymphoblastoid alpha-interferon: the Knodell histological activity index, serum levels of procollagen type III peptide, serum HCV-RNA, anti-alpha-interferon antibodies, and anti-HCV antibodies (C-100-3), all at month 12. Thirty-seven patients were studied. Fourteen patients were non-responders (38%), 15 patients experienced a sustained response (40.5%) and eight patients responded similarly but relapsed after alpha-interferon withdrawal (21.5%). A decrease in the histological activity index above 5, normalization of procollagen type III peptide levels (< 12 ng/ml) and the absence of viremia after treatment were all significantly associated with a sustained response (p = 0.008, p = 0.007 and p = 0.037, respectively). Anti-interferon antibodies were detected in only one non-responder patient. Anti-C-100-3 antibodies became undetectable at month 12 in 5 of the 15 sustained responders. The best prediction of sustained response was obtained from the three variables independent of multivariate analysis according to the following equation: F = 0.872 + 0.067 x K (decrease of histological index) -0.052 x P (procollagen type III peptide levels at month 12) -0.28 x R (HCV-RNA at month 12; R = 2 when present and R = 1 when absent). A score higher than 0 predicted sustained remission with a 100% sensitivity and specificity in this series of patients
Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I
We have previously shown that the administration of low doses of insulin-like growth factor-I (IGF-I) to CCl4-cirrhotic rats improves liver function and reduces fibrosis. To better understand the mechanisms behind the hepatoprotective effects of IGF-I, and to identify those genes whose expression is affected in cirrhosis and after IGF-1 treatment, we have performed differential display of mRNA analysis by means of polymerase chain reaction (PCR) in livers from control and CCl4-cirrhotic rats treated or not with IGF-I. We have identified 16 genes that were up- or down-regulated in the cirrhotic liver. IGF-I treatment partially normalized the expression of eight of these genes, including serine proteinase inhibitors such as serpin-2 and alpha-1-antichymotripsin, alpha-1-acid glycoprotein, and alpha-2u-globulin. Additionally, we show that IGF-I enhanced the regenerative activity in the cirrhotic liver, as determined by the increased expression of the proliferating cell nuclear antigen (PCNA). Finally, IGF-I treatment partially restored the expression of growth hormone receptor (GHR) and the levels of global genomic DNA methylation, which are reduced in human and experimental cirrhosis. Taken together, our observations confirm the hepatoprotective effects of IGF-I, and suggest that this action can be exerted in part through the normalization of liver gene expression, growth hormone (GH) responsiveness and global genomic DNA methylation
Novel compound shows in vivo anthelmintic activity in gerbils and sheep infected by Haemonchus contortus
8 páginas, 2 figuras, 2 tablas.The control of gastrointestinal nematodes in livestock is becoming increasingly difficult due to the limited number of available drugs and the rapid development of anthelmintic resistance. Therefore, it is imperative to develop new anthelmintics that are effective against nematodes. Under this context, we tested the potential toxicity of three compounds in mice and their potential anthelmintic efficacy in Mongolian gerbils infected with Haemonchus contortus. The compounds were selected from previous in vitro experiments: two diamine (AAD-1 and AAD-2) and one benzimidazole (2aBZ) derivatives. 2aBZ was also selected to test its efficacy in sheep. In Mongolian gerbils, the benzimidazole reduced the percentage of pre-adults present in the stomach of gerbils by 95% at a dose of 200 mg/kg. In sheep, there was a 99% reduction in the number of eggs shed in faeces after 7 days at a dose of 120 mg/kg and a 95% reduction in the number of worm adults present in the abomasum. In conclusion, 2aBZ could be considered a promising candidate for the treatment of helminth infections in small ruminants. © 2022, The Author(s).Financial support came from MINECO: RETOS (AGL2016-79813-C2-1R/2R) and MICINN/AEI (PID2020-
119035RB-100). EVG was funded by FPU17/00627, FPU17/05346; VCGA, MAB, MCP and LGP are recipients
of Junta de Castilla y León (JCyL) (LE082-18, LE051-18, LE135-19, LE096-20, respectively) and MMV by the
Spanish “Ramon y Cajal” Programme (Ministerio de Economía y competitividad; MMV, RYC-2015-18368).Peer reviewe
"Percentage of excess body mass index loss and cardiometabolic risk reduction in Peruvian adults undergoing sleeve gastrectomy"
"Objective: To assess the association between the percentage of excess body mass index loss
(%EBMIL) and cardiometabolic risk reduction in Peruvian adults undergoing laparoscopic sleeve
gastrectomy (LSG).
Methods: Retrospective cohort study conducted with adult patients who underwent LSG in a
bariatric clinic during 2016–2020. The outcome variable was cardiometabolic risk change (expressed in Δ) 1 year after LSG. To that effect, the variables total cholesterol, high-density
lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, very LDL (VLDL) cholesterol,
triglycerides, glucose, insulin, and HOMA-IR at baseline and after 12 months were considered.
The exposure variable was %EBMIL. Crude and adjusted β coefficients were estimated with linear regression models.
Results: Of the 110 patients analyzed, 68.2% were women, and the median patient age was 34.5
years. In the model adjusted for sex, age, and baseline BMI, we noted that each 25% increase in
%EBMIL resulted in a decrease in the values for total cholesterol, LDL, triglycerides, and insulin
by 10.36 mg/dL (p < 0.001), 7.98 mg/dL (p = 0.001), 13.35 mg/dL (p = 0.033), and 3.63
uU/mL (p = 0.040), respectively.
Conclusion: %EBMIL was associated with a decrease in total cholesterol, LDL, triglycerides, and
insulin levels, which could suggest a favorable cardiometabolic evolution during the first 12
months following LSG.
Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis
BACKGROUND: The exogenous administration of Insulin-like Growth Factor-I (IGF-I) induces hepatoprotective and antifibrogenic actions in experimental liver cirrhosis. To better understand the possible pathways behind the beneficial effect of IGF-I, the aim of this work was to investigate severe parameters involved in oxidative damage in hepatic tissue from cirrhotic animals treated with IGF-I (2 μg. 100 g(-1). day(-1)). Iron and copper play an important role in oxidative mechanisms, producing the deleterious hydroxyl radical (*OH) that peroxides lipid membranes and damages DNA. Myeloperoxidase (MPO) and nitric oxide (NO) are known sources of free radicals and induce reduction of ferritin-Fe(3+ )into free Fe(2+), contributing to oxidative damage. METHODS: Liver cirrhosis was induced by CCl(4 )inhalation in Wistar male rats for 30 weeks. Healthy controls were studied in parallel (n = 10). Fe and Cu were assessed by atomic absoption spectrometry and iron content was also evaluated by Perls' staining. MPO was measured by ELISA and transferrin and ferritin by immunoturbidimetry. iNOS expression was studied by immuno-histochemistry. RESULTS: Liver cirrhosis was histologically proven and ascites was observed in all cirrhotic rats. Compared to controls untreated cirrhotic rats showed increased hepatic levels of iron, ferritin, transferrin (p < 0.01), copper, MPO and iNOS expression (p < 0.01). However, IGF-treatment induced a significant reduction of all these parameters (p < 0.05). CONCLUSION: the hepatoprotective and antifibrogenic effects of IGF-I in cirrhosis are associated with a diminution of the hepatic contents of several factors all of them involved in oxidative damage
A large, ten-generation family with autosomal dominant preaxial polydactyly/triphalangeal thumb: Historical, clinical, genealogical, and molecular studies
We present a large, ten-generation family of 273 individuals with 84 people having preaxial polydactyly/triphalangeal thumb due to a pathogenic variant in the zone of polarizing activity regulatory sequence (ZRS) within the exon 5 of LMBR1. The causative change maps to position 396 of the ZRS, located at position c.423 + 4909C > T (chr7:156791480; hg38; LMBR1 ENST00000353442.10; rs606231153 NG_009240.2) in the intron 5 of LMBR1. The first affected individual with the disorder was traced back to mid-1700, when some settlers and workers established in Cervera de Buitrago, a small village about 82 km North to Madrid. Clinical and radiological studies of most of the affected members have been performed for 42 years (follow-up of the family by LFGA). Molecular studies have confirmed a pathogenic variant in the ZRS that segregates in this family. To the best of our knowledge, this is the largest family with preaxial polydactyly/triphalangeal thumb reported so far.Instituto de Salud Carlos III, Grant/Award Number: PI20/0105
Organizational climate and satisfaction of the external user in the hospitalization services of the Instituto Nacional de Salud del Niño, 2017
Introducción. El clima organizacional dentro de las instituciones de salud y la satisfacción del paciente se utilizan para evaluar y mejorar la calidad de los servicios de salud. Objetivo. Determinar el clima organizacional y la satisfacción del usuario externo sobre la atención medica recibida en los servicios de hospitalización del Instituto Nacional Salud del Niño (INSN). Métodos. En el año 2017 se aplicó una encuesta para calificar el clima organizacional a los trabajadores de los servicios de hospitalización del Departamento de Medicina del INSN. La satisfacción del usuario externo se midió mediante la encuesta SERVQUAL aplicada a los usuarios externos. Resultados. La calificación del clima organizacional fue de 76,3%, considerada como mejorable; y la satisfacción global del usuario externo fue de 64,4%. El clima organizacional en las dimensiones de identidad, comunicación organizacional y estructura lograron el calificativo de saludable y la dimensión remuneración obtuvo el calificativo de no saludable. La dimensión mejor valorada por los usuarios externos fue: ¿durante su hospitalización recibió visita médica todos los días?; y la menos valorada: ¿los trámites para el alta fueron rápidos?. Conclusión. La calificación global del clima organizacional fue de 76,3% y la satisfacción global del usuario externo fue de 64,4% en el INSN.Introduction. The organizational climate within health institutions and patient satisfaction are used to evaluate and improve the quality of health services. Objective. Determine the organizational climate and the satisfaction of the external user regarding the medical care received in the hospitalization services of the Instituto Nacional Salud del Niño (INSN). Methods. In the year 2017 a survey was applied to qualify the organizational climate to the workers of the hospitalization services of the Department of Medicine of the INSN. The satisfaction of the external user was measured through the SERVQUAL survey applied to external users. Results. The qualification of the organizational climate was 76,3%, considered as improvable; and the overall satisfaction of the external user was 64,4%. The organizational climate in the dimensions of identity, organizational communication and structure achieved the qualification of healthy and the remuneration dimension obtained the qualification of unhealthy. The dimension best valued by external users was: during your hospitalization did you receive a medical visit every day? and the least valued: were the procedures for discharge high?. Conclusion. The overall rating of the organizational climate was 76,3% and the overall satisfaction of the external user was 64,4% in the INSN
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination
Background: In Spain, the influenza vaccine effectiveness (VE) was estimated in the last three seasons using the observational study cycEVA conducted in the frame of the existing Spanish Influenza Sentinel Surveillance System. The objective of the study was to estimate influenza vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza-like illness (ILI) among the target groups for vaccination in Spain in the 2011-2012 season. We also studied influenza VE in the early (weeks 52/2011-7/2012) and late (weeks 8-14/2012) phases of the epidemic and according to time since vaccination. Methods: Medically attended patients with ILI were systematically swabbed to collect information on exposure, laboratory outcome and confounding factors. Patients belonging to target groups for vaccination and who were swabbed 4 months, respectively, since vaccination. A decrease in VE with time since vaccination was only observed in individuals aged ≥ 65 years. Regarding the phase of the season, decreasing point estimates were only observed in the early phase, whereas very low or null estimates were obtained in the late phase for the shortest time interval. Conclusions: The 2011-2012 influenza vaccine showed a low-to-moderate protective effect against medically attended, laboratory-confirmed influenza in the target groups for vaccination, in a late season and with a limited match between the vaccine and circulating strains. The suggested decrease in influenza VE with time since vaccination was mostly observed in the elderly population. The decreasing protective effect of the vaccine in the late part of the season could be related to waning vaccine protection because no viral changes were identified throughout the season
Comparison of body mass index (BMI) with the CUN-BAE body adiposity estimator in the prediction of hypertension and type 2 diabetes
Background Obesity is a world-wide epidemic whose prevalence is underestimated by BMI measurements, but CUN-BAE (Clínica Universidad de Navarra - Body Adiposity Estimator) estimates the percentage of body fat (BF) while incorporating information on sex and age, thus giving a better match. Our aim is to compare the BMI and CUN-BAE in determining the population attributable fraction (AFp) for obesity as a cause of chronic diseases. Methods We calculated the Pearson correlation coefficient between BMI and CUN-BAE, the Kappa index and the internal validity of the BMI. The risks of arterial hypertension (AHT) and diabetes mellitus (DM) and the AFp for obesity were assessed using both the BMI and CUN-BAE. Results 3888 white subjects were investigated. The overall correlation between BMI and CUN-BAE was R2 = 0.48, which improved when sex and age were taken into account (R2 > 0.90). The Kappa coefficient for diagnosis of obesity was low (28.7 %). The AFp was 50 % higher for DM and double for AHT when CUN-BAE was used. Conclusions The overall correlation between BMI and CUN-BAE was not good. The AFp of obesity for AHT and DM may be underestimated if assessed using the BMI, as may the prevalence of obesity when estimated from the percentage of BF
- …